Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Tests feedback and support to improve cardiac rehabilitation programs after heart attack

Tests feedback and support for rehabilitation centers treating adults after a heart attack.

Plain-language title generated from the registry record
Registry title: The Perfect-CR Implementation Study

Key facts

Where
Malmö, SwedenSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 79 years old?

Source: NCT05889416, who can take part

Where in Sweden

  • Skåne University HospitalMalmö, SwedenNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Skane University Hospital
Trial code
NCT05889416
Record updated
29 November 2024
Original description
The goal of this open-label cluster-randomized effectiveness-implementation hybrid trial is to study whether a) audit and feedback of cardiac rehabilitation service delivery within a national quality registry and b) structured implementation support can improve center-level adherence to guidelines and short and long-term patient-level outcomes.Read full original descriptionShow less

The Effect of Audit and Feedback Within a National Registry and Implementation Support on Guideline Adherence and Patient Outcomes in Cardiac Rehabilitation: an Open-label Cluster-randomized Effectiveness-implementation Hybrid Trial

The goal of this open-label cluster-randomized effectiveness-implementation hybrid trial is to study whether a) audit and feedback of cardiac rehabilitation service delivery within a national quality registry and b) structured implementation support can improve center-level adherence to guidelines and short and long-term patient-level outcomes.

Inclusion: Centres report to the SWEDEHEART registry; Diagnosis of a type 1 MI registered in the SWEDEHEART registry; Age 18-79 years at discharge from hospital; Attended at least two follow-up visits at CR centres included in the study.

Exclusion: Unwillingness to participate in the study; Patient-level; None.

Centre-level.

ClinicalTrials.gov NCT05889416